Navigation Links
New Disinfection Technology Expected To Combat Deadly CRE Threat
Date:3/21/2013

SAN FRANCISCO, March 21, 2013 /PRNewswire/ -- San Francisco-based Medizone International (MZEI:OB) (MZEI:QB), announced today that its patented, peer-reviewed disinfection system is 'more than capable' of eliminating CRE from hospital and health care environments.

Medizone CEO Edwin Marshall stated, "Given the growing public, media and health sector interest in the emergence of CRE  (Carbapenem-resistant Enterobacteriaceae) in hospitals as a highly antibiotic resistant cause of hospital acquired infections (HAI), we felt that it was important to make public the anticipated effectiveness of AsepticSure with CRE."

Dr Michael E. Shannon M.A ., M.Sc., M.D. President and Director of Medical Affairs for Medizone, added, "Although we are not permitted to conduct research on extremely dangerous pathogens such as CRE, I can say unequivocally that we have absolutely no difficulty destroying all of its relatives including Klebsiella and E coli which are commonly cited as examples of Enterobacteriaceae.

"These bacteria are among the easiest for our AsepticSure system to eliminate in that when we achieve a 6 log (99.9999%) kill with MRSA we are usually looking at a 7 log kill for Klebsiella and E coli (99.99999%). I therefore have no doubt that CRE can be completely eradicated from any contaminated space using our AsepticSure system."

AsepticSure has recently been trialed successfully at Belleville General Hospital in Ontario, Canada, and is also the recipient of a prestigious WHO award for innovation.

For press information on Medizone International, please contact:
Bruce Smeaton , Investor Relations, Medizone International, Inc.
T: 001-415-331-0202    E: bruce@medizoneint.com

Medizone International, Inc. is engaged in initial production and sales of its modular design AsepticSure® Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure.

This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

For more information, visit: www.medizoneint.com


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PDI Signs Agreement with HealthTrust for Surface Disinfection Products
2. ARAMARK Healthcare Offered Disinfection Robot Revolutionizes Hospital Sanitation Practices on The Doctors
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
5. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
6. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
9. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
10. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
11. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ ... Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - ... reach USD 779.8 Million by 2021 from USD 414.6 Million in ... of 2016 to 2021. Continue Reading ... ...
(Date:12/5/2016)... , December 5, 2016 According to a new ... and by Application - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", ... expected to reach $5,255 million by 2022, growing at a CAGR of 6.4% ... more than four-fifths share. Continue Reading ... ...
(Date:12/5/2016)... and PUNE, India , December 5, 2016 ... Allied Market Research, titled, "Global Cancer Biomarkers Market - Global ... cancer biomarkers market is projected to reach $15,737 million by ... 13.3% from 2016 to 2022. Omic technologies segment accounted for ... is expected to maintain its dominance during the forecast period. ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... ... lines. The goal of Castlewood Treatment Centers has always been to promote the ... as many people as possible. In that spirit, Castlewood has announced two new ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... Clinical Officer for the Florida Hospital West Florida Region. McGuinness brings experience in ... leading and engaging staff, physicians and leaders. , In her new role, that ...
(Date:12/5/2016)... ... ... has joined the Retina Group of New York (RGONY) specializing in uveitis and ... and has been providing tertiary medical and surgical retinal care on Long Island for over ... peers. Growing up in a family of doctors, Dr. Shah emulated the role of ...
(Date:12/5/2016)... ... December 05, 2016 , ... Z-Medica, LLC, a leading developer ... The American College of Surgeons (ACS) to provide basic bleeding control instructor training ... Basic” course is a pilot program that fulfills the intent of the White ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
Breaking Medicine News(10 mins):